Viridian Therapeutics Inc... (VRDN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
20.07
0.64 (3.29%)
At close: Jan 30, 2025, 3:59 PM
20.08
0.05%
After-hours Jan 30, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -4.1 | -7.47 | -2.97 | -0.53 | -0.35 | -2.74 | -7.57 | -4.28 | -8.01 | -10.89 | -178.15 | -52.78 |
PS Ratio | 3.10K | 528.93 | 79.53 | 55.73 | 3.37 | 10.70 | 50.14 | 16.25 | 35.77 | 19.90 | 89.13 | 86.38 |
PB Ratio | 2.21 | 2.37 | 1.26 | 0.49 | 0.95 | 1.75 | 5.21 | -166.3 | 8.72 | 14.35 | 189.86 | -17.75 |
P/FCF Ratio | -5.27 | -9.9 | -4.29 | -1.96 | -0.42 | -3.29 | -7.06 | -7.49 | -12.93 | -34.67 | -328.12 | -60.11 |
P/OCF Ratio | -5.29 | -9.99 | -4.32 | -1.96 | -0.42 | -3.34 | -7.13 | -7.5 | -13.16 | -38.84 | -329.46 | -61.14 |
OCF/S Ratio | -586.53 | -52.96 | -18.42 | -28.36 | -8.08 | -3.2 | -7.04 | -2.17 | -2.72 | -0.51 | -0.27 | -1.41 |
Debt / Equity Ratio | 0.05 | 0.01 | 0.00 | 0.00 | 0.53 | 0.20 | 0.26 | -3.21 | 0.11 | 0.01 | 0.34 | -1.06 |
Quick Ratio | 18.26 | 12.93 | 14.68 | 12.14 | 2.92 | 9.71 | 13.31 | 0.91 | 4.68 | 3.32 | 1.22 | 0.06 |
Current Ratio | 18.26 | 12.73 | 14.68 | 12.14 | 2.92 | 9.71 | 13.31 | 0.93 | 4.75 | 3.41 | 1.48 | 0.07 |
Asset Turnover | 0.00 | 0.00 | 0.01 | 0.01 | 0.15 | 0.13 | 0.08 | 0.78 | 0.20 | 0.53 | 1.18 | 1.58 |
Interest Coverage | -137.76 | -276.35 | -26.58K | -217.28 | -50.27 | -37.9 | -69.27 | -131.66 | -79.34 | -6.71 | -0.1 | -2.53 |
Return on Equity (ROE) | -0.54 | -0.32 | -0.42 | -0.92 | -2.69 | -0.64 | -0.69 | 38.88 | -1.09 | -1.32 | -1.07 | 0.34 |
Return on Assets (ROA) | -0.48 | -0.29 | -0.39 | -0.85 | -1.4 | -0.49 | -0.51 | -2.98 | -0.88 | -0.98 | -0.59 | -2.59 |
Return on Capital (ROIC) | -0.55 | -0.33 | -0.42 | -0.92 | -2.09 | -0.56 | -0.55 | 38.37 | -1.07 | -1.13 | -0.09 | 0.19 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.13 | -0.1 |
Gross Profit Margin | -321.02% | 57.39% | 79.08% | -2.60K% | -635.13% | -262.76% | -390.21% | 23.64% | 2.60% | 24.93% | 42.11% | 30.95% |
Net Profit Margin | -75.71K% | -7.08K% | -2.68K% | -10.57K% | -950.91% | -389.97% | -662.3% | -379.8% | -446.34% | -182.64% | -50.03% | -163.67% |
Pretax Profit Margin | -75.71K% | -7.33K% | -2.68K% | -10.54K% | -938.65% | -389.97% | -662.3% | -379.8% | -446.34% | -182.64% | -50.03% | -127.51% |
Operating Profit Margin | -81.04K% | -7.58K% | -2.69K% | -10.51K% | -941.02% | -394.51% | -662.8% | -374.83% | -440.78% | -158.96% | -4.55% | -91.4% |
FCF Margin | -58.94K% | -5.34K% | -1.85K% | -2.84K% | -810.13% | -325.41% | -709.79% | -216.78% | -276.64% | -57.38% | -27.16% | -143.71% |
EBITDA Margin | -74.70K% | -7.26K% | -2.66K% | -10.44K% | -913.47% | -376.21% | -645.04% | -374.83% | -433.53% | -155.62% | -1.11% | -88.12% |